Neonatal abstinence syndrome management in California birth hospitals: results of a statewide survey

J Perinatol. 2020 Mar;40(3):463-472. doi: 10.1038/s41372-019-0568-6. Epub 2020 Jan 7.

Abstract

Objective: Assess management of neonatal abstinence syndrome (NAS) in California hospitals to identify potential opportunities to expand the use of best practices.

Study design: We fielded an internet-based survey of 37 questions to medical directors or nurse managers at 145 birth hospitals in California.

Results: Seventy-five participants (52%) responded. Most respondents reported having at least one written protocol for managing NAS, but gaps included protocols for pharmacologic management. Newer tools for assessing NAS severity were not commonly used. About half reported usually or always using nonpharmacologic strategies; there is scope for increasing breastfeeding when recommended, skin-to-skin care, and rooming-in.

Conclusions: We found systematic gaps in care for infants with NAS in a sample of California birth hospitals, as well as opportunities to spread best practices. Adoption of new approaches will vary across hospitals. A concerted statewide effort to facilitate such implementation has strong potential to increase access to evidence-based treatment for infants and mothers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Breast Feeding / statistics & numerical data
  • California
  • Clonidine / therapeutic use
  • Health Care Surveys
  • Humans
  • Infant Care
  • Infant, Newborn
  • Inservice Training
  • Neonatal Abstinence Syndrome / diagnosis
  • Neonatal Abstinence Syndrome / drug therapy
  • Neonatal Abstinence Syndrome / therapy*
  • Opiate Substitution Treatment
  • Phenobarbital / therapeutic use
  • Severity of Illness Index

Substances

  • Analgesics, Opioid
  • Clonidine
  • Phenobarbital